Cargando…

Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications

Ovarian epithelial cancer (OEC) is the most lethal gynecologic malignancy. Despite current chemotherapeutic and surgical options, this high lethality can be attributed to multiple factors, including late-stage presentation. In order to optimize OEC treatment, it is important to highlight that it is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romero, Ignacio, Leskelä, Susanna, Mies, Belén Pérez, Velasco, Andrés Poveda, Palacios, José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573476/ https://www.ncbi.nlm.nih.gov/pubmed/33240438 http://dx.doi.org/10.1016/j.ejcsup.2020.02.001

Ejemplares similares

Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma
por: Leskela, Susanna, et al.
Publicado: (2019)

Molecular Heterogeneity of High Grade Colorectal Adenocarcinoma
por: Perna, Cristian, et al.
Publicado: (2021)

The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer
por: Dion, Ludivine, et al.
Publicado: (2020)

Regional and temporal heterogeneity of epithelial ovarian cancer tumor biopsies: implications for therapeutic strategies
por: Paracchini, Lara, et al.
Publicado: (2016)

Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy
por: Bai, Huimin, et al.
Publicado: (2016)

Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2021)

Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
por: Gil, Joan, et al.
Publicado: (2022)

The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma—A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
por: Pizarro, David, et al.
Publicado: (2023)

High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features
por: Rosa-Rosa, Juan Manuel, et al.
Publicado: (2019)

Genetic alterations and their therapeutic implications in epithelial ovarian cancer
por: Lapke, Nina, et al.
Publicado: (2021)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications
por: Lhermitte, Benoit, et al.
Publicado: (2023)

Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis
por: González-Martínez, Silvia, et al.
Publicado: (2021)

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
por: Rojas, Veronica, et al.
Publicado: (2016)

Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer
por: López-Guerrero, José Antonio, et al.
Publicado: (2015)

Cytological and molecular characterization of secretory breast carcinoma
por: Carretero‐Barrio, Irene, et al.
Publicado: (2022)

Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)

Cancer heterogeneity: implications for targeted therapeutics
por: Fisher, R, et al.
Publicado: (2013)

Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer
por: Pereira, Lloyd, et al.
Publicado: (2015)

Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer
por: WANG, YU, et al.
Publicado: (2012)

Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases
por: González-Martínez, Silvia, et al.
Publicado: (2022)

Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer
por: Blagden, Sarah P.
Publicado: (2015)

Morphological and molecular basis of ovarian serous carcinoma
por: Rosen, Daniel G, et al.
Publicado: (2010)

Morphological Heterogeneity of the Endoplasmic Reticulum within Neurons and Its Implications in Neurodegeneration
por: Sree, Sreesha, et al.
Publicado: (2021)

Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
por: Strauss, Robert, et al.
Publicado: (2011)

Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins
por: Gui, Ting, et al.
Publicado: (2014)

DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities
por: Ovejero-Sánchez, María, et al.
Publicado: (2023)

Implications of Molecular Heterogeneity for the Cooperativity of Biological Macromolecules
por: Solomatin, Sergey V., et al.
Publicado: (2011)

Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications
por: Parker, Nicole Renee, et al.
Publicado: (2015)

HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
por: Fransvea, Emilia, et al.
Publicado: (2009)

Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
por: Jacquemin, Valerie, et al.
Publicado: (2022)

Clinical, morphologic and molecular heterogeneity of HPV-associated oropharyngeal cancer
por: Lim, Yvonne X., et al.
Publicado: (2023)

GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
por: González Martín, A., et al.
Publicado: (2013)

Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes
por: Gong, Ting-Ting, et al.
Publicado: (2023)

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
por: Huo, Yu-Jia, et al.
Publicado: (2022)

Bacteriophage Interactions With Epithelial Cells: Therapeutic Implications
por: Górski, Andrzej, et al.
Publicado: (2021)

Management of advanced ovarian cancer in Spain: an expert Delphi consensus
por: Redondo, Andres, et al.
Publicado: (2021)

Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
por: Strauss, Robert, et al.
Publicado: (2011)

The Molecular Mechanisms of Actions, Effects, and Clinical Implications of PARP Inhibitors in Epithelial Ovarian Cancers: A Systematic Review
por: Lau, Chien-Hui, et al.
Publicado: (2022)

Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers
por: López-García, M. Ángeles, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v017lplgvh6doumoppgtvgiedl